110 related articles for article (PubMed ID: 19507191)
1. PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation.
Blalock WL; Grimaldi C; Fala F; Follo M; Horn S; Basecke J; Martinelli G; Cocco L; Martelli AM
J Cell Physiol; 2009 Oct; 221(1):232-41. PubMed ID: 19507191
[TBL] [Abstract][Full Text] [Related]
2. PKR plays a positive role in osteoblast differentiation by regulating GSK-3β activity through a β-catenin-independent pathway.
Yoshida K; Okamura H; Ochiai K; Hoshino Y; Haneji T; Yoshioka M; Hinode D; Yoshida H
Mol Cell Endocrinol; 2012 Sep; 361(1-2):99-105. PubMed ID: 22484461
[TBL] [Abstract][Full Text] [Related]
3. Varicella-zoster virus requires a functional PI3K/Akt/GSK-3alpha/beta signaling cascade for efficient replication.
Rahaus M; Desloges N; Wolff MH
Cell Signal; 2007 Feb; 19(2):312-20. PubMed ID: 16934436
[TBL] [Abstract][Full Text] [Related]
4. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
5. Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.
Kuemmerle JF
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G101-10. PubMed ID: 15297258
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
7. Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival.
Hartmann W; Küchler J; Koch A; Friedrichs N; Waha A; Endl E; Czerwitzki J; Metzger D; Steiner S; Wurst P; Leuschner I; von Schweinitz D; Buettner R; Pietsch T
Clin Cancer Res; 2009 Jul; 15(14):4538-45. PubMed ID: 19584164
[TBL] [Abstract][Full Text] [Related]
8. GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis.
Lin CF; Chen CL; Chiang CW; Jan MS; Huang WC; Lin YS
J Cell Sci; 2007 Aug; 120(Pt 16):2935-43. PubMed ID: 17666435
[TBL] [Abstract][Full Text] [Related]
9. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
10. Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-kappaB activation but not GSK3beta activity.
Bhattacharya S; Ray RM; Johnson LR
Apoptosis; 2005 Aug; 10(4):759-76. PubMed ID: 16133867
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation.
Chen EY; Mazure NM; Cooper JA; Giaccia AJ
Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110
[TBL] [Abstract][Full Text] [Related]
12. Neuronal pentraxin 1 induction in hypoxic-ischemic neuronal death is regulated via a glycogen synthase kinase-3α/β dependent mechanism.
Russell JC; Kishimoto K; O'Driscoll C; Hossain MA
Cell Signal; 2011 Apr; 23(4):673-82. PubMed ID: 21130869
[TBL] [Abstract][Full Text] [Related]
13. PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.
Ruvolo VR; Kurinna SM; Karanjeet KB; Schuster TF; Martelli AM; McCubrey JA; Ruvolo PP
J Biol Chem; 2008 Dec; 283(51):35474-85. PubMed ID: 18957415
[TBL] [Abstract][Full Text] [Related]
14. PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation.
Scarpa M; Singh P; Bailey CM; Lee JK; Kapoor S; Lapidus RG; Niyongere S; Sangodkar J; Wang Y; Perrotti D; Narla G; Baer MR
Mol Cancer Ther; 2021 Apr; 20(4):676-690. PubMed ID: 33568357
[No Abstract] [Full Text] [Related]
15. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia.
Falà F; Blalock WL; Tazzari PL; Cappellini A; Chiarini F; Martinelli G; Tafuri A; McCubrey JA; Cocco L; Martelli AM
Mol Pharmacol; 2008 Sep; 74(3):884-95. PubMed ID: 18577685
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
Soda M; Willert K; Kaushansky K; Geddis AE
Cell Signal; 2008 Dec; 20(12):2317-23. PubMed ID: 18804163
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways leading to oxidative stress-induced phosphorylation of Akt.
Lahair MM; Howe CJ; Rodriguez-Mora O; McCubrey JA; Franklin RA
Antioxid Redox Signal; 2006; 8(9-10):1749-56. PubMed ID: 16987028
[TBL] [Abstract][Full Text] [Related]
18. GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3.
Jensen J; Brennesvik EO; Lai YC; Shepherd PR
Cell Signal; 2007 Jan; 19(1):204-10. PubMed ID: 16934435
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
20. Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes.
Nandy D; Asmann YW; Mukhopadhyay D; Basu A
J Cell Mol Med; 2010 Jun; 14(6B):1396-407. PubMed ID: 19754670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
